Literature DB >> 23619923

Variability of ffDNA in maternal plasma does not prevent correct classification of trisomy 21 using MeDIP-qPCR methodology.

Skevi Kyriakou1, Elena Kypri, Christiana Spyrou, Evdokia Tsaliki, Voula Velissariou, Elisavet A Papageorgiou, Philippos C Patsalis.   

Abstract

OBJECTIVE: The goal of this study is to evaluate the amount of free fetal DNA (ffDNA), total DNA, and 'fetal fraction' found in maternal plasma and whether these influence the enrichment ratios of differentially methylated regions (DMRs) and the correct classification of trisomy 21 using the methylated DNA immunoprecipitation-quantitative polymerase chain reaction (MeDIP-qPCR)-based noninvasive prenatal diagnostic methodology applied in peripheral blood.
METHODS: Absolute quantification of ffDNA using DYS14 and total DNA using β-globin was applied in 83 maternal plasma samples. The quantification values for all 83 samples were correlated with the enrichment ratios of all seven DMRs and D-values that were obtained from the diagnostic formula of MeDIP-qPCR method.
RESULTS: Our analysis concluded that trisomy 21 samples had significantly higher ffDNA and total DNA levels compared with those of normal samples. Enrichment ratios of the majority of DMRs studied exhibited no association with ffDNA, total DNA, and 'fetal fraction', and only a small portion of DMRs exhibited moderate association. Correlation studies of ffDNA, total DNA, and fetal fraction with the diagnostic D-value showed weak to no association but without affecting the classification of trisomy 21.
CONCLUSION: Overall, the variability of ffDNA and total DNA among maternal samples does not affect the correct trisomy 21 classification using MeDIP-qPCR methodology applied in peripheral blood.
© 2013 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23619923     DOI: 10.1002/pd.4140

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  3 in total

1.  Targeted capture enrichment assay for non-invasive prenatal testing of large and small size sub-chromosomal deletions and duplications.

Authors:  Maria C Neofytou; Kyriakos Tsangaras; Elena Kypri; Charalambos Loizides; Marios Ioannides; Achilleas Achilleos; Petros Mina; Anna Keravnou; Carolina Sismani; George Koumbaris; Philippos C Patsalis
Journal:  PLoS One       Date:  2017-02-03       Impact factor: 3.240

2.  The Epigenome View: An Effort towards Non-Invasive Prenatal Diagnosis.

Authors:  Elisavet A Papageorgiou; George Koumbaris; Elena Kypri; Michael Hadjidaniel; Philippos C Patsalis
Journal:  Genes (Basel)       Date:  2014-04-09       Impact factor: 4.096

3.  Development of a new methylation-based fetal fraction estimation assay using multiplex ddPCR.

Authors:  Marios Ioannides; Achilleas Achilleos; Skevi Kyriakou; Elena Kypri; Charalambos Loizides; Kyriakos Tsangaras; Louiza Constantinou; George Koumbaris; Philippos C Patsalis
Journal:  Mol Genet Genomic Med       Date:  2019-12-10       Impact factor: 2.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.